US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

238.79

+1.340.56%

Volume:7K

Turnover:1.72M

Market Cap:479.13M

PE:- -

High:238.79

Open:237.30

Low:236.64

Close:237.45

52wk High:246.55

52wk Low:171.63

Shares:2.01M

Float Shares:2.01M

Volume Ratio:0.97

T/O Rate:0.36%

Dividend:0.95

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says

MT Newswires Live

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-29

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

Revolution Medicines Seen Having 'Strong' Rasonque Launch in Pancreatic Cancer, UBS Says

MT Newswires Live

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

US Drugmakers Turn to China for Licensing Deals

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

Regeneron (REGN) Receives a Hold from Bernstein

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BBH/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":238.79,"timestamp":1791221929497,"preClose":237.4531,"halted":0,"volume":7225,"delay":0,"changeRate":0.005630164440893742,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Trading","change":1.3369,"latestTime":"10-05 13:48:45 EDT","open":237.2999,"high":238.79,"low":236.6444,"amount":1718362.9325,"amplitude":0.009036,"askPrice":240.03,"askSize":300,"bidPrice":239.81,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":237.4531,"sharesOutstanding":1976503,"nav":237.39591,"aum":476335613.78,"dividendRate":0.003978,"bidAskSpread":0.001118,"postHourTrading":{"tag":"盘后","latestPrice":237.58,"preClose":237.4531,"latestTime":"19:30 EDT","volume":23,"amount":5462.9441,"timestamp":1790983804584,"change":0.1269,"changeRate":0.000534,"amplitude":0},"volumeRatio":0.973299,"impliedVol":0.203,"impliedVolPercentile":0.6215},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.973299,"shares":2006503,"dividePrice":0.9498,"high":238.79,"amplitude":0.009036,"preClose":237.4531,"low":236.6444,"week52Low":171.63,"pbRate":"--","week52High":246.55,"institutionHeld":0,"latestPrice":238.79,"committee":-0.5,"eps":0,"divideRate":0.003978,"volume":7225,"delay":0,"ttmEps":0,"open":237.2999,"prevYearClose":189.2649,"prevWeekClose":237.4531,"prevMonthClose":244.575,"prevQuarterClose":244.575,"fiveDayClose":245.3373,"twentyDayClose":241.1222,"sixtyDayClose":205.546},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671246994","title":"Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246994","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246994?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:39","pubTimestamp":1790699968,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  needs \"better\" terms from a potential renegotiated agreement with Sanofi  over their drug development collaboration, RBC said in a report Tuesday.The note said the firms have been providing breadcrumbs on ongoing negotiations. RBC conducted a buyside poll to gauge what investors may be expecting from a renegotiation to drive Regeneron shares.There was an almost even split between investors suggestingthat Dupixent follow-ons into the joint venture and better economics were sufficient and those wanting to see an additional sweetener in cash or another asset from Sanofi, the report said.\"Overall it suggests to us that REGN needs to come away with better terms on its follow-ons than what is currently the case for dupi, and perhaps could extract some additional upside in the form of cash or another joint asset from partner SNY,\" it said.RBC has a sector perform rating with a price target of $737.Price: 748.59, Change: -3.66, Percent Change: -0.49","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU1974910355.USD","BBH","LU2468319806.SGD","IE00BFXG1179.USD","LU2106854487.HKD","LU2023250504.SGD","SNY","LU0823434583.USD","BK4585","BK4588","REGN","SNYNF","IBB","LU2362541273.HKD","LU0289739699.SGD","LU0882574055.USD","LU0823434740.USD","BK4007","LU1917777945.USD","IBBQ","LU0058720904.USD","LU0320765992.SGD","TBXU","BK4139","LU0114720955.EUR","LU2362541513.USD","LU2362540622.SGD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671243545","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-29","url":"https://stock-news.laohu8.com/highlight/detail?id=2671243545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671243545?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:01","pubTimestamp":1790694066,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-09-29Nasdaq 100.NDXTop PerformersPercent ChangeLumentum Holdings Inc.LITE.OQ+6.7%ARM Holdings PLCARM.OQ+5.3%Nebius Group NVNBIS.OQ+5.0%CoreWeave, Inc.CRWV.OQ+4.3%Marvell Technology, Inc.MRVL.OQ+4.2%Bottom PerformersPercent ChangePalo Alto Networks, Inc.PANW.OQ-3.0%Walmart Inc.WMT.OQ-2.9%Ferrovial N.V.FER.OQ-2.3%T-Mobile US IncTMUS.OQ-2.1%Gilead Sciences, Inc.GILD.OQ-1.9%The Nasdaq 100.NDXgained 91.01 points, or 0.30%, to 30,367.82 and recorded no new highs and one new low. 37 stocks rose and 64 fell as declining issues outnumbered advancers by about a 1.7-to-1 ratio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL8N45L1LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMHX","ARMA","TMUS","LU1585245621.USD","QQQA","LU0320765489.SGD","LU0106261612.USD","LU2931357623.SGD","LU1119994496.HKD","LU1316542783.SGD","PSQ","LU1623119135.USD","LU0265550359.USD","LU1983260115.SGD","LU0256863902.USD","EGGY","IE00BMPRXQ63.HKD","LU1823568750.SGD","LU0823416689.USD","QMAR","QLD","LU1934455194.USD","LU2471134879.HKD","BK4532","DTCR","BK4020","MVLL","LU0314106906.USD","LU2430703095.HKD","LU0205193047.USD","LU0012050646.USD","03034","LU2089985449.USD","BK4604","PALU","LU0029864427.USD","BK4609","SG9999015978.USD","ARMU","QDEC","LU2294711713.HKD","FER","03455","FSTA","LU0329931090.USD","LU0531971165.HKD","LITU","TBXU","LU2322448791.USD","LU0738911758.USD","LU2095319765.USD","LU0417517546.SGD","LU1003077747.HKD","LU1815333072.USD","BK4504","IE0001KFT4U8.USD","CRWX","LU1023059063.AUD","CWII","BIB","LU1720051108.HKD",".HXC","LU1621767810.EUR","LU1035773651.USD","SG9999015945.SGD","BK4588","LU0957808578.USD","LU0096362180.USD","PANW","GILD","LU1674673428.USD","LU0950373646.USD","LU0238689110.USD","LU1917777945.USD","LAZR","LU1267930573.SGD","BK4155","LU2361044949.HKD","LU0476273544.USD","LU2244417387.USD","LU2264538146.SGD","LU1923622291.USD","BK4578","LU2112291526.USD","QID","LITE","LU0957791311.USD","SPAM","AIFD","LU0082616367.USD","HAKY","IE00BN8TJ469.HKD","LU0823434740.USD","LU1235294995.USD","LU1066051498.USD","IE00B19Z3B42.SGD","NJUL","LU1861559042.SGD","CWVX","BK4077","LU1992135399.USD","LUMA","LU0353189680.USD","MRVX","LU0320765992.SGD","LU0211327993.USD","BK4581","LU0240878834.USD","LU2430703251.USD","LU0128525929.USD","IE00B19Z3581.USD","NEBX","LU0056508442.USD","LU1712237335.SGD","CIBR","GB00BDT5M118.USD","LU0786609619.USD","IE00BD4GTV84.USD","IE00B7SZLL34.SGD","LU2125909759.SGD","NJAN","LU0708994859.HKD","IE00BSNM7G36.USD","LU0154236417.USD","LU0251131958.USD","LU0127658192.USD","IE00BD4GTT62.SGD","LU0061475181.USD","LU1116320737.USD","XLP","LU0097036916.USD","NDX","LU0823414551.USD","IE00BMPRXR70.SGD","IHAK","LU1548497426.USD","LU0823421416.USD","LU2210149790.SGD","TQQQ","IE0002270589.USD","LU2360032135.SGD","BK4132","LU2125154778.USD","QQQX","NBIL","LU1061106388.HKD","LU0348723411.USD","LU0310800379.SGD","LU2317271919.USD","LU1280957306.USD","NBIZ","07568","GPIQ","LU0823434583.USD","IGV","LU0289739699.SGD","LU2592432038.USD","LU1084165304.USD","LU2087625088.SGD","IE00B19Z9505.USD","NOCT","LU0114720955.EUR","BUG","CRWG","LU0861579265.USD","LU1814569148.SGD","IE0004086264.USD","SG9999000418.SGD","LU1066051811.HKD","ARMG","AIPI","NBIC","FTXL","SG9999015986.USD","LU0208291251.USD","03086","TRUO","LU0965509283.SGD","TQQY","GTEK","LU0070302665.USD","ARTY","LU1934455863.HKD","ARM","IE00B775SV38.USD","QQQ","07266","IE00BD4GTW91.USD","LU0314104364.USD","NBIS","IBB","PSWD","LU2384288077.EUR","LU0122379950.USD","BK4550","LU0266013472.USD","LU0823431647.USD","LU0061474960.USD","LU2357627491.SGD","LU2473716301.USD","IE00BLSP4452.SGD","LU2361044865.SGD","LU2249611893.SGD","LU2355687059.USD","BBH","LU2125154935.USD","LU1720051017.SGD","LU2360107168.USD","LU0170899867.USD","LU2750360641.GBP","UGE","IE00BBT3K403.USD","BK4549","BK4116","LU1261432733.SGD","XNTK","LU0949170772.SGD","LU2430703178.SGD","IE0034235188.USD","IBBQ","QQQM","BK4568","WUGI","LU1571399168.USD","LU0823421333.USD","LU0965508806.USD","LU2272731865.HKD","LU0444973449.USD","LU2324357040.USD","LU2746668461.USD","LU1366192091.USD","IE000M9KFDE8.USD","LU1974910355.USD","LU1989764748.USD","LU0719512351.SGD","LU0289960550.SGD","LU2361045086.USD","SG9999001424.SGD","LITC","LU0048573561.USD","MRVL","FXL","PANG","LU1852331112.SGD","CRWU","LU0265550946.USD","IE00B3S45H60.SGD","LU1989764664.SGD","SPRX","BK4566","BK4597","LU2247934214.USD","BK4534","LU0742534661.SGD","LU0211328371.USD","LU2023250843.SGD","NBIG","FAI","IE00B19Z8X17.USD","LU2750360997.AUD","LU0251142724.SGD","TMED","LU2272731782.SGD","BK4596","HK0000914686.HKD","LU2023250504.SGD","IE00BZ1G4Q59.USD","LU2471134952.CNY","BK4559","LU0256863811.USD","LU0444971666.USD","LU0205194284.USD","LU2272731600.USD","LU2089984988.USD","LU2125909916.SGD","LU1988902786.USD","IE00B19Z8W00.USD","LU0965509010.AUD","LU1066053197.SGD","07261","LU1642822529.SGD",".IXIC","LU1066051225.USD","LU1934455277.USD","LU0058720904.USD","LU0240877869.USD","LU0310799852.SGD","LU0640476718.USD","CLOD","BK4605","LU0274383776.USD","LU1861220033.SGD","LU1621768115.EUR","TRFK","LU1116320901.HKD","LU0545039389.USD","LU1267930490.SGD","LU2097829019.USD","WMT","LU0149725797.USD","LU1674673691.USD","LU2322448957.HKD","BK4585","LU0511384066.AUD","IE00B1BXHZ80.USD","LU1057294990.SGD","LITG","FOTO","LU0187121727.USD","SOXY","LU1815336760.USD","LU0061474705.USD","LU1169589451.USD","BK4129","LU1992135472.HKD","LU2357125470.USD","IE0004091025.USD","IE00B3T34201.USD","PALD","LU0289961442.SGD","LU1506573853.SGD","SG9999015952.SGD","LU1169590202.USD","ARMW","LU1778281490.HKD","IE00BKVL7J92.USD","LU1839511570.USD","LU0289739343.SGD","BK4097","LU1232071149.USD","CRWV","WCBR","BK4598","LU1621767737.EUR","LU2471134523.USD","LU2471134796.USD","LU2106854487.HKD","LU2458330169.SGD","LU2543165471.USD","LU0661504455.SGD","LU1069347547.HKD","BK4515","LU0081259029.USD","LU0823431563.USD","BK4543","02834","LU1046421795.USD","LU0965509101.SGD","CORD","LU0823414478.USD","LU2286300806.USD","RTH","LU0267386448.USD","WCLD","LU2746668974.SGD","LU2357305700.SGD","LITZ","LU1861558580.USD","LU0889565916.HKD","LU1804176565.USD","LU0553294199.USD","LU1037948897.HKD","FDTX","LU1861215975.USD","LU1037948541.HKD","LU0276348264.USD","MEDI","LU1303367103.USD","BK4583","07522","LU2381873111.SGD","LITX","MRVU","LU2505996681.GBP","BK4533","AIS","LU2505996509.AUD","09086","LU2098885051.SGD","BK4560","LU2458330243.SGD","LU2290526834.HKD","BK4139","BK4141","SQQQ","LU2087621335.USD","LU2210150020.SGD","LU2506951792.HKD","IE00BLSP4239.USD","LU1621768206.USD","LU2265009873.SGD","BK4561","HK0000914660.USD","LU0642271901.SGD","HK0000819398.USD","09834","WMTI","LU2468319806.SGD","LU0109394709.USD","LU0077335932.USD","LU0859254822.USD","LU0882574055.USD","LU1430594728.SGD","IE00BMPRXN33.USD","LU0175139822.USD","LU2461242641.AUD","LU0234570918.USD","LU1064131342.USD","LU0353189763.USD","BMED","NAPR","LU0329931173.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216266","title":"Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216266?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680206,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Summit Therapeutics (SMMT), Ocular Therapeutix (OC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-ocular-therapeutix-ocul-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU0823434583.USD","LU0889565916.HKD","HCSG","BK4137","LU2362541273.HKD","OCUL","SMMT","BBH","BK4139","XLV","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU0882574055.USD","BK4581","XBI","LU1974910355.USD","LU2089984988.USD","LU2106854487.HKD","BK4007","LU0128526141.USD","LABU","TBXU","IBB","LU2362541513.USD","IBBQ","LU0823416689.USD","BK4588","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU2488822045.USD","LU0109394709.USD","LU0029874061.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215313","title":"Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215313?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:31","pubTimestamp":1790677875,"startTime":"0","endTime":"0","summary":"A federal judge has dismissed a securities fraud lawsuit against Regeneron Pharmaceuticals ($REGN) and several of its executives, with the court di...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/court-dismisses-regeneron-pharmaceuticals-regn-securities-lawsuit-over-eylea-and-eylea-hd-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/court-dismisses-regeneron-pharmaceuticals-regn-securities-lawsuit-over-eylea-and-eylea-hd-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0109394709.USD","LU2362540622.SGD","LU0823434583.USD","TBXU","LU1974910355.USD","LU2468319806.SGD","LU0320765992.SGD","LU1917777945.USD","LU0058720904.USD","LU2106854487.HKD","LU2237438978.USD","LU2362541273.HKD","IBBQ","LU0289739699.SGD","LU0823434740.USD","LU0114720955.EUR","LU0823416689.USD","BK4139","LU2023250504.SGD","BK4585","LU2362541513.USD","IBB","BBH","LU0882574055.USD","LU0053666078.USD","BK4588","REGN","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290718","title":"Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671290718?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:30","pubTimestamp":1790674217,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 4D Molecular Therapeutics (FDMT), Envista Holdings...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-4d-molecular-therapeutics-fdmt-envista-holdings-nvst-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034390439.USD","LU0128526141.USD","LU2362541513.USD","LU2468319806.SGD","LU0823416689.USD","BK4082","LU0648000940.SGD","LU0029874061.USD","BK4137","LU0823434583.USD","BK4585","LU1917777945.USD","LU0823434740.USD","LU2023250504.SGD","NVST","IBB","LU0320765992.SGD","BK4581","FDMT","LU2362540622.SGD","LU0889565916.HKD","LU0882574055.USD","LU2089984988.USD","XBI","IE00B19Z6F94.USD","LU0053666078.USD","HCSG","LABU","LU0114720955.EUR","LU1974910355.USD","XLV","LU0058720904.USD","LU1201861165.SGD","BK4588","TBXU","LU0109394709.USD","BBH","LU0130518102.USD","LU0289739699.SGD","LU2106854487.HKD","LU2362541273.HKD","LU0477156797.USD","REGN","LU2237438978.USD","BK4139","LU0130103400.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671329926","title":"SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671329926","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671329926?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:23","pubTimestamp":1790666588,"startTime":"0","endTime":"0","summary":"SoftOx names Dr. Bruce Montgomery to chair Clinical Advisory BoardSoftOx appointed Dr. A. Bruce Montgomery to establish and chair its Clinical Advisory Board ahead of a planned Phase 2b SIS study.Boar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLbDg5Mx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00B19Z3B42.SGD","LU0058720904.USD","BK4578","IBBQ","LU2089984988.USD","BK4583","TMED","GILD","MEDI","BIB","BK4550","LU1057294990.SGD","LU0965509283.SGD","LU0234570918.USD","LU1674673428.USD","LU1934455277.USD","LU1066053197.SGD","BK4585","SG9999015986.USD","LU0965509101.SGD","IE00BSNM7G36.USD","LU1778281490.HKD","LU1061106388.HKD","LU0289739699.SGD","BBH","LU2357627491.SGD","LU0122379950.USD","TBXU","LU0859254822.USD","IBB","IE0002270589.USD","IE00B3T34201.USD","LU2112291526.USD","LU0965509010.AUD","BK4139","LU0823416689.USD","LU1839511570.USD","LU1934455863.HKD","LU1066051498.USD","LU0882574055.USD","BK4588","LU1571399168.USD","BK4568","LU1934455194.USD","BK4566","IE00B7SZLL34.SGD","LU0320765992.SGD","IE00BZ1G4Q59.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671013268","title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2671013268","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671013268?lang=en_us&edition=fundamental","pubTime":"2026-09-29 06:00","pubTimestamp":1790632843,"startTime":"0","endTime":"0","summary":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sells USD 743,436 in common sharesRevolution Medicines Chief Global Commercialization Officer Anthony Mancini reported sales","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLcdFr5m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","IE00BFTCPJ56.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","IDNA","IE0009355771.USD","LU0109394709.USD","IE00B2B36J28.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","CANC","PTH","BK4139","BBH","IE00BJJMRZ35.SGD","IE0009354923.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257160","title":"Teva Wins US FDA Approval for Xgeva Biosimilar Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257160?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625646,"startTime":"0","endTime":"0","summary":"Teva wins US FDA approval for Xgeva biosimilar DEGEVMATeva won FDA clearance for DEGEVMA (denosumab-adet), a biosimilar to Amgen’s Xgeva.Label covers Xgeva’s full uses, including prevention of bone co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4w4Bbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","IE0002141913.USD","BK4566","LU2112291526.USD","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","LU2468319806.SGD","SG9999014039.USD","IBB","IE00BJT1NW94.SGD","IE00BQXX3D17.EUR","BK4112","LU2242646821.SGD","LU0889565916.HKD","LU1571399168.USD","LU0320765992.SGD","LU1061106388.HKD","LU2089984988.USD","TBXU","BK4585","BK4599","IBBQ","IE00B64PRP62.GBP","LU0122379950.USD","IE00B4R5TH58.HKD","SG9999014021.USD","AMGN","PBE","LU2242652126.USD","PJP","LU0289739699.SGD","IE00BN0W2V16.EUR","BBH","LU0314104364.USD","LU1057294990.SGD","IE00BKPKM429.USD","LU1983299246.USD","SG9999001440.SGD","BK4534","BK4139","BIB","IE00BN0W2W23.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252933","title":"Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620623,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix tumbles on rival Kodiak's trial win, analyst calls selloff overdone** Shares of Ocular TherapeutixOCUL.Ofall 18.8% to $7.84 in afternoon trading** Kodiak Sciences'KOD.Oexperime","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K1CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU2468319806.SGD","LU2023250504.SGD","BK4007","REGN","LU0053666078.USD","LU0889565916.HKD","LU0114720955.EUR","LU1917777945.USD","LU1974910355.USD","BK4588","LU2362541513.USD","IBBQ","LU2237438978.USD","LU0823434583.USD","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","OCUL","BK4139","LU2362541273.HKD","BK4505","LU0109394709.USD","BBH","LU0882574055.USD","LU0823416689.USD","KOD","LU0823434740.USD","LU2106854487.HKD","LU0289739699.SGD","BK4585","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671259773","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671259773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671259773?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:00","pubTimestamp":1790611227,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN) and Kodiak Sciences (KOD). Regeneron (REGN) Citi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","KOD","LU0029874061.USD","LU0889565916.HKD","BK4585","XBI","LU0114720955.EUR","LU1974910355.USD","BK4581","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","BK4137","IBB","LU0053666078.USD","LU0823434740.USD","XLV","IBBQ","LABU","BK4505","BK4588","LU0128526141.USD","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","HCSG","LU0109394709.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670259517","title":"Revolution Medicines Seen Having 'Strong' Rasonque Launch in Pancreatic Cancer, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670259517","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670259517?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:58","pubTimestamp":1790611096,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) is expected to have a \"strong\" launch for its Rasonque drug in second-line pancreatic ductal adenocarcinoma patients, and in some first-line patients as well, UBS Securitie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RVMD","IDNA","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0889565916.HKD","IE0009355771.USD","PTH","CANC","BBH","IE00BFTCPJ56.SGD","IE0009354923.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670564812","title":"Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670564812","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670564812?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:23","pubTimestamp":1790609027,"startTime":"0","endTime":"0","summary":"UPDATE 1-Mirum's liver infection drug lowers virus levels in late-stage studySept 28 (Reuters)-Mirum PharmaceuticalsMIRM.Oon Monday said its experimental hepatitis drug reduced levels of the virus in ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K14L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0122379950.USD","BIB","SG9999015952.SGD","LU0320765992.SGD","LU0859254822.USD","TMED","LU2468319806.SGD","LU1023059063.AUD","IE00B19Z3581.USD","BBH","LU1585245621.USD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","BK4566","MEDI","LU2324357040.USD","LU1430594728.SGD","LU0965509101.SGD","IE00B3T34201.USD","LU0882574055.USD","LU1934455863.HKD","LU2357627491.SGD","LU0861579265.USD","SG9999015986.USD","LU1839511570.USD","MIRM","GILD","IE00BKVL7J92.USD","LU1066053197.SGD","BK4585","LU0234570918.USD","LU1066051498.USD","IBB","BMED","LU2087621335.USD","IE00BSNM7G36.USD","BK4139","LU0889565916.HKD","TBXU","LU2112291526.USD","LU0965509283.SGD","BK4588","LU0058720904.USD","LU1778281490.HKD","LU1934455194.USD","IBBQ","IE0002270589.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670620256","title":"Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670620256","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670620256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:11","pubTimestamp":1790608260,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences more than doubled Monday after two experimental eye drugs succeeded in a late-stage trial, positioning the biopharmaceutical company to get its first product to market.Kodiak","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU2089984988.USD","BK4505","KOD","BK4588","BBH","LU0823416689.USD","TBXU","LU2023250504.SGD","LU0109394709.USD","LU1974910355.USD","LU2362541273.HKD","BK4585","LU0823434583.USD","LU2468319806.SGD","LU2362540622.SGD","BK4139","IBB","LU0889565916.HKD","LU0823434740.USD","IBBQ","LU0289739699.SGD","LU2237438978.USD","OTLK","LU0320765992.SGD","LU0882574055.USD","LU0058720904.USD","LU0114720955.EUR","LU2106854487.HKD","REGN","LU0053666078.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256598","title":"Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256598","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256598?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:00","pubTimestamp":1790607600,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen’s latest Sjögren’s trial success adds to its pipeline, while Repatha growth and MariTide trials shape the AMGN stock outlook for 2026.","market":"sh","thumbnail":"https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262189733-stocks-amgen-stock-forecast-sjogrens-trial-maritide-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","LU2237443622.USD","PBE","LU2089984988.USD","LU0122379950.USD","LU1829250122.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","BIB","LU2237443382.USD","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","LU0289739699.SGD","LU1571399168.USD","LU2237443465.HKD","LU2237443549.SGD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","BBH","PJP","AZNH","BK4581","IE00BJJMRZ35.SGD","LU0029864427.USD","IE0009355771.USD","LU2112291526.USD","LU0432979614.USD","LU2237443895.HKD","LU0109394709.USD","AMGN","LU0889565916.HKD","LU2236285917.USD","BK4533","LU2456880835.USD","TBXU","IE00B3T34201.USD","LU2237443978.SGD","SG9999001440.SGD","LU0708994859.HKD","LU2242652126.USD","IBBQ","BK4007","IE00BJT1NW94.SGD","LU0128525929.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU1868837136.USD","IE000M9KFDE8.USD","LU0316494557.USD","LU1868836757.USD","XLV","LU0053666078.USD","LU2347655073.USD","LU1941712348.USD","IE00BWXC8680.SGD","LU0058720904.USD","LU2028103732.USD","LU1732799900.SGD","LU2361044865.SGD","LU1261432733.SGD","LU2471134523.USD","LU0203201768.USD","LU0265550359.USD","IE00BVYPNV92.GBP","BK4568","LU1069347547.HKD","LU2433249047.HKD","LU0323591593.USD","LU1929549753.HKD","BMY","LU2357627491.SGD","MEDI","LU0109394709.USD","LU1988902786.USD","LU2237438978.USD","IE00BBT3K403.USD","KURE","IE00B19Z3581.USD","LLYX","LU0306807586.USD","LU2089283258.USD","FHLC","LU0912757837.SGD","LU2125154778.USD","LU2756315318.SGD","LU0607220059.USD","MHIP","LU1066051225.USD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0708995401.HKD","LU1989772840.SGD","LU0061475181.USD","LU1934455863.HKD","THNR","LU1670711123.USD","LU2362541513.USD","LU0244354667.USD","PFE","LU2236285917.USD","LU2417539215.USD","LU1670710588.SGD","LU0320765059.SGD","SGXZ81514606.USD","SG9999015945.SGD","LU1699723380.USD","SGXZ99366536.SGD","LU0417517546.SGD","LU0455707207.USD","LU1989772923.USD","LU0265550946.USD","LU0708994859.HKD","LU1064131342.USD","IE000BZT7R73.USD","LU0158827948.USD","LU0267386448.USD","LU0109391861.USD","LU2324357040.USD","PJP","LU0079474960.USD","LU1883839398.USD","LU2097828474.EUR","LU0471298694.HKD","LU0823416689.USD","IE00B3T34201.USD","LU2456880835.USD","LU1917777945.USD","IE00B4JS1V06.HKD","LU0942090050.USD","LU2213496289.HKD","LU0321505868.SGD","LU0320765646.SGD","LU2361045086.USD","LU2112291526.USD","GDOC","LU0326950275.SGD","LU0256863811.USD","LU2108987350.USD","SG9999002224.SGD","ELIS","LU0210536198.USD","LU1066053197.SGD","ELIL","LU0861579265.USD","LU1548497426.USD","LU2168564222.USD","LU1116320901.HKD","LU0122379950.USD","LU0502904849.HKD","IE0002270589.USD","SG9999002232.USD","LU0158827781.USD","IE00BFTCPJ56.SGD","REGN","LU0823434740.USD","LU1934455194.USD","SGXZ31699556.SGD","SG9999001440.SGD","LU0726765562.USD","LU2362540622.SGD","LU2552382132.HKD","LU1093756168.USD","SG9999003800.SGD","IHE","LU0170899867.USD","LU1732800096.USD","SG9999013999.USD","LLYZ","LU0345770993.USD","CURE","LU0070302665.USD","LU2097828805.USD","LU1934455277.USD","LU1868836914.USD","LU1691799644.USD","LLY","LU1366192091.USD","LU0130517989.USD","SG9999015978.USD","IE00B4R5TH58.HKD","SG9999014542.SGD","LU0096364046.USD","LU0203347892.USD","LU0432979614.USD","MRK","LU0859254822.USD","LU1035775433.USD","LU1236620834.HKD","LU0057025933.USD","LU0211331839.USD","LU0795875169.SGD","LU0882574139.USD","BK4532","LU1032466523.USD","IE00BKDWB100.SGD","LU2168563687.JPY","LU1037948541.HKD","LU2360032135.SGD","LU1551013425.SGD","LU2746668461.USD","IE000WAW04H5.SGD","SG9999015986.USD","LU0964807845.USD","LU0069063385.USD","LU1035773651.USD","LU0310799852.SGD","TRUH","LU0466842654.USD","LU2168564495.EUR","IE00BK4W5L77.USD","LU1003077747.HKD","LU0965509101.SGD","LU2462157665.USD","LU0203345920.USD","LU2125154935.USD","SG9999015341.SGD","AGNG","IE00BJJMRX11.SGD","LU2211815571.USD","IE0001KFT4U8.USD","LU0203202063.USD","IE0005OL40V9.USD","SG9999014898.SGD","LU0965508806.USD","LU2125909593.SGD","LU0225284248.USD","LU1941712264.USD","LU2491050154.USD","LU1280957306.USD","LU1983299246.USD","IE00B3PB1722.GBP","LU2746668974.SGD","IE00BVYPNW00.USD","LU2237443549.SGD","LU2491049909.HKD","IBB","LU0463099449.HKD","LU0198837287.USD","01801","LU2023250504.SGD","IE00BGHQF631.EUR","PAWZ","LU1894683348.USD","LU0097036916.USD","LU2129689605.HKD","LU2237443895.HKD","LU0820561818.USD","BK4581","LU0820562030.AUD","LU2111349929.HKD","LU1267930573.SGD","SG9999018865.SGD","IE00BJT1NW94.SGD","IE000MB6IJN5.SGD","LU2552382215.SGD","LU1244550221.USD","BK4533","IBBQ","IE00BN29S564.USD","LU0661504455.SGD","IE00BLSP4239.USD","LU2602419157.SGD","LU2242644610.SGD","LU0545039389.USD","LU0133085943.USD","LU0320765489.SGD","LU0683600562.USD","LU1037948897.HKD","LU1093756325.SGD","LU2125909247.SGD","LU0237698245.USD","LU0689472784.USD","LU0980610538.SGD","LU2237443382.USD","VHT","LU0114720955.EUR","IE0000B7K699.USD","WDNA","LU0289739343.SGD","SG9999014914.USD","LU2750360641.GBP","IE00B19Z3B42.SGD","RXL","LU2097828557.USD","IE00B1XK9C88.USD","LU1244550494.USD","LU0094547139.USD","LU1066051498.USD","LU1868837300.USD","SGXZ57979304.SGD","LU1868836591.USD","LU0006306889.USD","LU2242646821.SGD","LU2237443465.HKD","IE00B775H168.HKD","LU2750360997.AUD","IE00BFXG1179.USD","LU0238689110.USD","IE00BSNM7G36.USD","LU0648001328.SGD","BK4588","LU2461242641.AUD","LU0289739699.SGD","LU0738911758.USD","LU0965509010.AUD","IXJ","BK4592","IE0004445239.USD","LU1201861249.SGD","LU0306806265.USD","LU2168564065.EUR","GB00BDT5M118.USD","LU1074936037.SGD","BK1161","IE000F7OJYX1.SGD","LU1670628061.USD","LU0321505439.SGD","LU0130102774.USD","LU2097828714.EUR","LU0029864427.USD","LU0234570918.USD","LU2023250843.SGD","LU1831875114.USD","LU0456855351.SGD","LU2089984988.USD","LU2106854487.HKD","LU2063271972.USD","LU2471134879.HKD","LU0477156953.USD","LU2328871848.SGD","SG9999011175.SGD","LU2552382058.USD","LU0471298777.SGD","IE0004445015.USD","LU1670627923.USD","LU1670710661.SGD","LU0868494617.USD","LU2087621335.USD","LU1923622614.USD","LU1804176565.USD","LU1267930730.SGD","LU0289961442.SGD","LU0823434583.USD","LU2264538146.SGD","BK4550","IE00B42XCP33.USD","LU0353189680.USD","LU1712237335.SGD","LU2596442595.SGD","GLAM","LU1069344957.HKD","LU0320765992.SGD","LU1236620750.USD","LU0965509283.SGD","LU2271345857.HKD","HRTS","LU0354030511.USD","IE0009355771.USD","LU1291159041.SGD","LU0795875086.SGD","SG9999014567.USD","MEDX","IE00BLSP4452.SGD","LU1670711040.USD","LU0640476718.USD","LU2468319806.SGD","LU1496350502.SGD","IE00BK4W5M84.HKD","IE00BFSS7M15.SGD","SG9999001176.SGD","LU2097828631.EUR","LLII","LU2360106947.USD","BK4139","LU0949170772.SGD","LU1894683264.USD","LU2129689431.USD","SG9999017495.SGD","LU0072461881.USD","IE00B2B36J28.USD","LU1720051108.HKD","LU2237443978.SGD","SGXZ51526630.SGD","LU1839511570.USD","HK0000165453.HKD","LU0511384066.AUD","SG9999018857.SGD","SG9999014559.SGD","SG9999014880.SGD","LU0234572021.USD","SG9999015952.SGD","BK4559","PPH","LU1232071149.USD","IE00BJJMRY28.SGD","LU1323610961.USD","LU1066051811.HKD","LU0985481810.HKD","LU2471134952.CNY","LU0124676726.USD","LU1814569148.SGD","SG9999014906.USD","TMED","LU1979441026.SGD","LU0211328371.USD","LU1496350171.SGD","IE00BN8TJ469.HKD","LU2237443622.USD","LU1061106388.HKD","LU0266013472.USD","LU1551013342.USD","BMED","LU1629891620.HKD","LU1127390331.HKD","LU1162221912.USD","IYH","LU0174119429.USD","LU0553294199.USD","LU0345770308.USD","LU2168564149.EUR","LU2488822045.USD","LU2347655156.SGD","LU0256863902.USD","SG9999001176.USD","LU2462591350.SGD","LU1571399168.USD","ILDR","LU0943347566.SGD","LU0149534421.HKD","BK4599","LU2089284900.SGD","LU1057294990.SGD","LU0882574055.USD","LU2896262040.SGD","LU2087625088.SGD","LU1969619763.USD","LU0985320562.USD","TBXU","BK1583","LU2242652126.USD","BK4585","LU1430594728.SGD","IE00BKPKM429.USD","LU1585245621.USD","LU0208291251.USD","SG9999014575.USD","LU2361044949.HKD","LU1023059063.AUD","IE00BFSS8Q28.SGD","IE00BJLML261.HKD","ABBV","LU0889565916.HKD","BK4534","BBH","BK1589","LU1116320737.USD","LU2491050071.SGD","LU0098860793.USD","LU1188198961.HKD","LU0385154629.USD","LU2023251221.USD","LU1244550577.SGD","IE00B1BXHZ80.USD","LU1974910355.USD","LU2265009873.SGD","LU0395794307.EUR","LU2756315664.SGD","LU2129689514.USD","LU2357305700.SGD","LU0689626769.HKD","LU2471134796.USD","LU1145028129.USD","LU1989771016.USD","LU0225283273.USD","LU0472753341.HKD","IE000SO60NU8.SGD","LU0128525929.USD","IE00B7KXQ091.USD","LU0868494708.USD","SG9999015358.SGD","LU1718418525.SGD","LU0672654240.SGD","BK4516","LU2023250330.USD","LU2362541273.HKD","LU1623119135.USD","BK4566","LU0787776722.HKD","LU0786609619.USD","CANC","LU0211327993.USD","BK4007","IE00BDGV0183.EUR","IE0002141913.USD","LU0225771236.USD","LU2133065610.SGD","LU1267930490.SGD","LU1720051017.SGD","LU0354030438.USD","JDOC","LU0820561909.HKD","OZEM","FTXH","LU0353189763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4532","BK4566","IE00B19Z3B42.SGD","LU1934455863.HKD","SG9999015952.SGD","MEDI","SG9999015978.USD","LU2468319806.SGD","TMED","BCDF","LU2112291526.USD","BIB","BBH","IE00BN0W2V16.EUR","GILD","LU1839511570.USD","LU0965509101.SGD","LU0965509283.SGD","IE00B3T34201.USD","LU1430594728.SGD","LU1571399168.USD","BK4583","LU0823416689.USD","TBXU","IE00B3QW5Z07.USD","BK4568","IBB","IE00B19Z3581.USD","IE00BN0W2W23.USD","XLO","IE00BKPKM429.USD","IBBQ","LU1061106388.HKD","LU1037948897.HKD","LU0861579265.USD","BMED","IE00BQXX3C00.GBP","LU1934455277.USD","LU2089984988.USD","LU1066051498.USD","LU0234570918.USD","LU2210150020.SGD","LU2210149790.SGD","IE00BKVL7J92.USD","LU0859254822.USD","LU1066053197.SGD","SG9999014021.USD","LU2087621335.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239992","title":"Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239992","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239992?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592624,"startTime":"0","endTime":"0","summary":"BUZZ-Kodiak Sciences rises after eye-disease drugs meet trial goals** Shares of drug developer Kodiak SciencesKOD.Orise 43.9% to $46.56 premarket** Co says its experimental drugs Zenkuda and tabirafusp-ted met the main goals of a late-stage trial in patients with wet age-related macular degeneration** Both drugs achieved vision gains at one year that were not inferior to aflibercept, the comparison treatment** Wet age-related macular degeneration causes abnormal blood vessels to leak beneath the retina and can lead to loss of central vision** About 54% of Zenkuda patients reached a six-month dosing interval, potentially reducing the number of eye injections needed** Both drugs showed safety broadly consistent with aflibercept; Kodiak plans further analyses to identify which patients may benefit most from tabirafusp-ted** Co plans to seek US approval for Zenkuda in Q4 2026, using results from five successful late-stage studies across three retinal diseases** KOD up 15.7% YTD, as of last","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","KOD","LU0889565916.HKD","BK4585","LU0114720955.EUR","LU1974910355.USD","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","IBB","LU0053666078.USD","LU0109394709.USD","IBBQ","BK4505","BK4588","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","LU0823434740.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670808280","title":"Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670808280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670808280?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:33","pubTimestamp":1790584380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.3% to 5.50 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.This was the stock's fifth consecutive day of losses.Sino Biopharmaceutical Ltd. closed 36% short of its 52-week high of HK$8.54, which the company reached Oct. 8.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 0.6% and Amgen Inc. remained unchanged.Trading volume totaled 57.5 million shares, compared to the 50-day average of 82.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0868494617.USD","TBXU","LU0889565916.HKD","IE0002141913.USD","PBE","BK1515","IE00BJT1NW94.SGD","BK4533","LU0320765992.SGD","BK4599","BBH","01177","SG9999001440.SGD","LU0109394709.USD","LU1983299246.USD","IE00B2B36J28.USD","LU2242646821.SGD","AMGN","LU1057294990.SGD","LU0058720904.USD","BK4581","91335","IBB","BK1521","BK4534","BK4585","BK1191","LU2089984988.USD","LU2468319806.SGD","BIB","BK1589","IE00BJJMRZ35.SGD","BK4588","PJP","IE00BZ08YS42.EUR","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE00BZ08YT58.USD","LU1571399168.USD","BK4139","IE00B4R5TH58.HKD","LU0122379950.USD","LU2242652126.USD","LU1061106388.HKD","LU2112291526.USD","IE0009355771.USD","IE00BZ08YR35.GBP","LU1023059063.AUD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471175","title":"Regeneron (REGN) Receives a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471175?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:55","pubTimestamp":1790427321,"startTime":"0","endTime":"0","summary":"Bernstein analyst Eve Burstein maintained a Hold rating on Regeneron yesterday and set a price target of $756.00. The company’s shares closed yeste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU2023250504.SGD","LU0889565916.HKD","LU2468319806.SGD","BK4139","LU0058720904.USD","LU0823434583.USD","REGN","LU0882574055.USD","BBH","LU0289739699.SGD","LU1917777945.USD","LU0823434740.USD","LU2237438978.USD","TBXU","LU2362540622.SGD","LU0823416689.USD","BK4588","LU0053666078.USD","LU0109394709.USD","BK4585","LU2106854487.HKD","LU0114720955.EUR","LU2362541513.USD","LU2089984988.USD","LU2362541273.HKD","LU0320765992.SGD","LU1974910355.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471177","title":"Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471177?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:40","pubTimestamp":1790426416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A) and Regeneron (REGN) with bullish sentim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-agilent-a-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-agilent-a-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1917777945.USD","LU0889565916.HKD","LU2362541273.HKD","BK4139","IE00BN0W2W23.USD","LU2237438978.USD","LU2362540622.SGD","LU0823416689.USD","LU1543694498.USD","LU2468319806.SGD","HCSG","LU2362541513.USD","IE00BN0W2T93.GBP","LABU","LU0289739699.SGD","LU2041044095.USD","LU0128526141.USD","LU2413666426.HKD","A","IE00BN0W2V16.EUR","BK4137","LU2106854487.HKD","LU2023250504.SGD","LU0058720904.USD","XBI","LU2413666699.HKD","BK4588","XLV","LU1974910355.USD","LU0823434740.USD","LU2092937221.SGD","LU0320765992.SGD","LU2089279066.USD","BK4121","LU2229751404.USD","LU1165135440.EUR","BBH","LU0347712357.USD","LU2089984988.USD","LU0114720955.EUR","IBBQ","LU0053666078.USD","LU0029874061.USD","LU0823434583.USD","LU0109394709.USD","BK4581","IBB","BK4585","TBXU","REGN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}